112 related articles for article (PubMed ID: 38218560)
1. Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.
Vikström S; Syriopoulou E; Andersson TM; Eriksson H
J Am Acad Dermatol; 2024 May; 90(5):963-969. PubMed ID: 38218560
[TBL] [Abstract][Full Text] [Related]
2. Reference-Adjusted Loss in Life Expectancy for Population-Based Cancer Patient Survival Comparisons-with an Application to Colon Cancer in Sweden.
Andersson TM; Rutherford MJ; Møller B; Lambert PC; Myklebust TÅ
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1720-1726. PubMed ID: 35700010
[TBL] [Abstract][Full Text] [Related]
3. The Proportion Cured of Patients with Resected Stage II-III Cutaneous Melanoma in Sweden.
Eriksson H; Utjés D; Olofsson Bagge R; Gillgren P; Isaksson K; Lapins J; Schultz IL; Lyth J; Andersson TM
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070092
[TBL] [Abstract][Full Text] [Related]
4. A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
Isaksson K; Katsarelias D; Mikiver R; Carneiro A; Ny L; Olofsson Bagge R
Ann Surg Oncol; 2019 Sep; 26(9):2839-2845. PubMed ID: 31111349
[TBL] [Abstract][Full Text] [Related]
5. Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy.
Leontyeva Y; Bower H; Gauffin O; Lambert PC; Andersson TM
BMC Med Res Methodol; 2022 May; 22(1):130. PubMed ID: 35501701
[TBL] [Abstract][Full Text] [Related]
6. Income disparities in loss in life expectancy after colon and rectal cancers: a Swedish register-based study.
Syriopoulou E; Osterman E; Miething A; Nordenvall C; Andersson TM
J Epidemiol Community Health; 2024 May; 78(6):402-408. PubMed ID: 38514169
[TBL] [Abstract][Full Text] [Related]
7. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
8. Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy.
Leontyeva Y; Lambe M; Bower H; Lambert PC; Andersson TM
BMC Med Res Methodol; 2023 Dec; 23(1):291. PubMed ID: 38087236
[TBL] [Abstract][Full Text] [Related]
9. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
Eriksson H; Lyth J; Andersson TM
Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
[TBL] [Abstract][Full Text] [Related]
10. Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
Hieken TJ; Glasgow AE; Enninga EAL; Kottschade LA; Dronca RS; Markovic SN; Block MS; Habermann EB
J Womens Health (Larchmt); 2020 Sep; 29(9):1160-1167. PubMed ID: 32105561
[No Abstract] [Full Text] [Related]
11. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
[TBL] [Abstract][Full Text] [Related]
12. Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021: A National Observational Cohort Study of 25 720 Patients With Stage IA to IV Melanoma.
Helvind NM; Brinch-Møller Weitemeyer M; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR
JAMA Dermatol; 2023 Nov; 159(11):1213-1222. PubMed ID: 37650576
[TBL] [Abstract][Full Text] [Related]
13. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
[TBL] [Abstract][Full Text] [Related]
14. Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.
Syriopoulou E; Gasparini A; Humphreys K; Andersson TM
Breast Cancer Res; 2022 Feb; 24(1):15. PubMed ID: 35197123
[TBL] [Abstract][Full Text] [Related]
15. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
[TBL] [Abstract][Full Text] [Related]
16. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
Lee AY; Droppelmann N; Panageas KS; Zhou Q; Ariyan CE; Brady MS; Chapman PB; Coit DG
Ann Surg Oncol; 2017 Apr; 24(4):939-946. PubMed ID: 27804026
[TBL] [Abstract][Full Text] [Related]
17. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
[TBL] [Abstract][Full Text] [Related]
18. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
[TBL] [Abstract][Full Text] [Related]
19. Understanding the impact of sex and stage differences on melanoma cancer patient survival: a SEER-based study.
Smith AJ; Lambert PC; Rutherford MJ
Br J Cancer; 2021 Feb; 124(3):671-677. PubMed ID: 33144697
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway.
Winge-Main A; Robsahm TE; Nyakas M; Festervoll G; Torkilseng E; Thybo S; Pati S; Carroll R
Future Oncol; 2023 Jan; 19(3):205-215. PubMed ID: 36974621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
